Earl Douglas

Insider Reports History

Location
Franklin, TN
Signature
Earl Douglas, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Earl Douglas:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. SVP, General Counsel Stock Option (Right to buy) 539,072 $1,421,624 $9.62 02 Feb 2026 Direct
Allogene Therapeutics, Inc. SVP, General Counsel Common Stock 564,948 $994,308 $1.76 02 Feb 2026 Direct
Allogene Therapeutics, Inc. SVP, General Counsel Restricted Stock Unit 152,480 02 Feb 2026 Direct

Insider Reports Filed by Earl Douglas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALLO Allogene Therapeutics, Inc. 02 Feb 2026 3 -$40,304 4 SVP, General Counsel 04 Feb 2026, 17:12
ALLO Allogene Therapeutics, Inc. 03 Feb 2025 1 -$10,951 4 SVP, General Counsel 05 Feb 2025, 16:16
ALLO Allogene Therapeutics, Inc. 24 Jan 2025 2 $0 4 SVP, General Counsel 28 Jan 2025, 20:16
ALLO Allogene Therapeutics, Inc. 21 Aug 2024 1 -$78,843 4 SVP, General Counsel 23 Aug 2024, 16:15
ALLO Allogene Therapeutics, Inc. 25 Jan 2024 2 $0 4 SVP, General Counsel 31 Jan 2024, 17:48
ALLO Allogene Therapeutics, Inc. 14 Aug 2023 3 $0 4 GENERAL COUNSEL 17 Aug 2023, 19:57
ALLO Allogene Therapeutics, Inc. 14 Aug 2023 0 $0 3 GENERAL COUNSEL 17 Aug 2023, 15:50